Vanguard Group’s UnitedHealth UNH Stock Holding History

Vanguard Group’s Portfolio UNH Stock Details UNH Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$28.4B	Buy	90,920,375 +190,790	+0.2%	+$59.5M	0.46%	25
2025 Q1	$47.5B	Buy	90,729,585 +5,583,343	+7%	+$2.92B	0.86%	15
2024 Q4	$43.1B	Buy	85,146,242 +192,644	+0.2%	+$97.5M	0.75%	15
2024 Q3	$49.7B	Buy	84,953,598 +1,005,240	+1%	+$588M	0.89%	14
2024 Q2	$42.8B	Sell	83,948,358 -456,897	-0.5%	-$233M	0.82%	14
2024 Q1	$41.8B	Buy	84,405,255 +544,740	+0.6%	+$269M	0.83%	13
2023 Q4	$44.2B	Buy	83,860,515 +250,291	+0.3%	+$132M	0.96%	12
2023 Q3	$42.2B	Sell	83,610,224 -286,917	-0.3%	-$145M	1.04%	11
2023 Q2	$40.3B	Sell	83,897,141 -453,487	-0.5%	-$218M	0.96%	12
2023 Q1	$39.9B	Buy	84,350,628 +298,248	+0.4%	+$141M	1.02%	10
2022 Q4	$44.6B	Buy	84,052,380 +1,082,511	+1%	+$574M	1.21%	4
2022 Q3	$41.9B	Buy	82,969,869 +851,994	+1%	+$430M	1.23%	6
2022 Q2	$42.2B	Buy	82,117,875 +1,486,962	+2%	+$764M	1.19%	8
2022 Q1	$41.1B	Buy	80,630,913 +1,147,051	+1%	+$585M	0.97%	10
2021 Q4	$39.9B	Buy	79,483,862 +315,811	+0.4%	+$159M	0.91%	11
2021 Q3	$30.9B	Buy	79,168,051 +601,194	+0.8%	+$235M	0.77%	13
2021 Q2	$31.5B	Sell	78,566,857 -91,377	-0.1%	-$36.6M	0.78%	13
2021 Q1	$29.3B	Sell	78,658,234 -434,313	-0.5%	-$162M	0.79%	12
2020 Q4	$27.7B	Sell	79,092,547 -688,191	-0.9%	-$241M	0.8%	13
2020 Q3	$24.9B	Sell	79,780,738 -946,402	-1%	-$295M	0.82%	13
2020 Q2	$23.8B	Buy	80,727,140 +5,654,194	+8%	+$1.67B	0.84%	11
2020 Q1	$18.7B	Buy	75,072,946 +1,920,001	+3%	+$479M	0.8%	13
2019 Q4	$21.5B	Buy	73,152,945 +2,430,561	+3%	+$715M	0.73%	16
2019 Q3	$15.4B	Buy	70,722,384 +186,884	+0.3%	+$40.6M	0.57%	30
2019 Q2	$17.2B	Sell	70,535,500 -1,892,425	-3%	-$462M	0.65%	24
2019 Q1	$17.9B	Buy	72,427,925 +966,889	+1%	+$239M	0.7%	19
2018 Q4	$17.8B	Buy	71,461,036 +2,118,487	+3%	+$528M	0.8%	13
2018 Q3	$18.4B	Buy	69,342,549 +1,073,505	+2%	+$286M	0.72%	14
2018 Q2	$16.7B	Buy	68,269,044 +587,193	+0.9%	+$144M	0.7%	17
2018 Q1	$14.5B	Buy	67,681,851 +913,899	+1%	+$196M	0.63%	21
2017 Q4	$14.7B	Buy	66,767,952 +965,574	+1%	+$213M	0.64%	21
2017 Q3	$12.9B	Buy	65,802,378 +1,223,760	+2%	+$240M	0.6%	23
2017 Q2	$12B	Buy	64,578,618 +1,588,516	+3%	+$295M	0.59%	26
2017 Q1	$10.3B	Buy	62,990,102 +2,778,336	+5%	+$456M	0.53%	31
2016 Q4	$9.64B	Buy	60,211,766 +1,541,051	+3%	+$247M	0.54%	27
2016 Q3	$8.21B	Buy	58,670,715 +1,456,792	+3%	+$204M	0.48%	33
2016 Q2	$8.08B	Buy	57,213,923 +1,123,084	+2%	+$159M	0.5%	33
2016 Q1	$7.23B	Buy	56,090,839 +1,593,895	+3%	+$205M	0.47%	36
2015 Q4	$6.41B	Buy	54,496,944 +981,470	+2%	+$115M	0.43%	41
2015 Q3	$6.21B	Buy	53,515,474 +869,512	+2%	+$101M	0.45%	35
2015 Q2	$6.42B	Buy	52,645,962 +795,235	+2%	+$97M	0.43%	41
2015 Q1	$6.13B	Buy	51,850,727 +1,769,953	+4%	+$209M	0.42%	41
2014 Q4	$5.06B	Buy	50,080,774 +1,117,635	+2%	+$113M	0.36%	44
2014 Q3	$4.22B	Buy	48,963,139 +706,705	+1%	+$61M	0.33%	49
2014 Q2	$3.94B	Buy	48,256,434 +423,592	+0.9%	+$34.6M	0.31%	50
2014 Q1	$3.92B	Buy	47,832,842 +456,054	+1%	+$37.4M	0.33%	48
2013 Q4	$3.57B	Buy	47,376,788 +298,466	+0.6%	+$22.5M	0.31%	52
2013 Q3	$3.37B	Buy	47,078,322 +794,935	+2%	+$56.9M	0.33%	47
2013 Q2	$3.03B	Buy	+46,283,387	New	+$3.03B	0.32%	50